One in Five Pharmacies in Blocks Access to Suboxone

  • Post author:
  • Post category:News
  • Reading time:2 mins read

A new study, published in the journal Drug and Alcohol Dependence, found that only one in five pharmacies will fill a prescription for the life-changing Medication-Assisted Treatment (MAT) drug Suboxone. Suboxone is considered a gold standard treatment for opioid use disorder by the FDA. Just this morning, the Biden administration announced that they are decreasing barriers to prescribing the drug.

Sadly, research shows that although a doctor may prescribe Suboxone, also known as buprenorphine, to a person in need, a pharmacy may block access during a critical time in their lives. Without access to MAT, many people will succumb to their opioid use disorder.

The Research on Suboxone and Pharmacies

The researchers did the study after learning, anecdotally, about patients having trouble filling prescriptions for Suboxone. “Buprenorphine is a vital, life-saving medication for people with opioid use disorder, but improving access has been a problem for a variety of …

Continue Reading One in Five Pharmacies in Blocks Access to Suboxone

New AUD Treatment, AD04, Drug Targets Genotypes

  • Post author:
  • Post category:News
  • Reading time:2 mins read

Adial Pharmaceuticals, Inc. has filed a Fast Track application with the US Food and Drug Administration (FDA) for its lead drug candidate, AD04. The drug is meant to target people with specific genes for whom other alcohol addiction therapies have failed. To take the drugs, a person must be diagnosed with alcohol use disorder.

Why Fast-Track AD04?

Several medication-assisted treatment options exist for alcoholics, but they are not considered to fail-proof or even useful for most people. They also carry a level of stigma that prevents doctors from prescribing them.

In America, treatment for alcohol use disorder often focuses on total abstinence, which many people with alcohol use disorder reject or, for whatever reason, are unable to achieve. While several drugs, including Topomax, have shown to be effective at preventing compulsive drinking, few treatment centers feel comfortable recommending a drug that allows people to continue drinking. (Other drugs make people …

Continue Reading New AUD Treatment, AD04, Drug Targets Genotypes

Medication-Assisted Treatment for Meth Addiction Being Tested

  • Post author:
  • Post category:News
  • Reading time:3 mins read

For the past few years, an addiction epidemic has raced across the U.S. While opioids have been taking lives through overdoses, another dangerous addiction has silently raged; methamphetamine. Until recently, there were no medications to help people cope with the withdrawal and intense desire to use that causes meth addiction to be so nefarious. New Medication-Assisted Treatment (MAT) research shows that a powerful combination of medications — injectable naltrexone and oral bupropion — can help people stay sober. This study would be the first time MAT has been successfully helped people with meth addiction.

What Was The Study About?

The clinical trial tested two drugs that have already been approved for opioid addiction but are already used off-label to treat alcoholism in some places. The study combined injectable naltrexone and oral bupropion and measured their safety and efficacy when treating meth addiction.  The test used subjects who were considered to

Continue Reading Medication-Assisted Treatment for Meth Addiction Being Tested